1. Home
  2. SABS vs VHC Comparison

SABS vs VHC Comparison

Compare SABS & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$18.56

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABS
VHC
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
181.4M
79.2M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
SABS
VHC
Price
$3.92
$18.56
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
253.6K
16.2K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$114,698.00
$106,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2020.00
52 Week Low
$1.00
$3.68
52 Week High
$6.60
$29.00

Technical Indicators

Market Signals
Indicator
SABS
VHC
Relative Strength Index (RSI) 59.35 40.61
Support Level $3.54 $18.21
Resistance Level $4.08 $22.27
Average True Range (ATR) 0.30 1.99
MACD -0.04 -0.34
Stochastic Oscillator 75.28 11.60

Price Performance

Historical Comparison
SABS
VHC

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: